Market revenue in 2022 | USD 19.1 million |
Market revenue in 2030 | USD 119.1 million |
Growth rate | 25.7% (CAGR from 2022 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or Conditions, Metabolic Diseases, Infectious Diseases |
Key market players worldwide | Walgreens Boots Alliance Inc, Microsoft Corp, Unlearn.AI, Mendel.ai, Deep Lens |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trial solutions for patient matching market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.04% in 2022. Horizon Databook has segmented the Canada ai-based clinical trial solutions for patient matching market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada ai-based clinical trial solutions for patient matching market , including forecasts for subscribers. This country databook contains high-level insights into Canada ai-based clinical trial solutions for patient matching market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account